Lung

Most recent

Other

CamBMT1: a proof-of-principle phase Ib/randomized phase II study of afatinib penetration into brain metastases for patients undergoing neurosurgical resection, both with and without prior low-dose, targeted radiotherapy

Baird RD, et al. ESMO 2016:1318 Background Brain metastases occur in 20–40% of all patients with cancer, and 30–50% of patients with locally advanced non-small cell lung cancer will relapse in the central nervous system. Failure of drugs to cross the blood-brain...

Twitter feed

Dr. Irwindeep Sandhu provides an analysis of the TOURMALINE-MM3 study with post-ASCT patients receiving #ixazomib m… https://t.co/ll9s4q7vCL
h J R
Dr. Brian Leber discusses long-term follow-up of patients with #myelofibrosis treated with #JAK inhibitors #EHA2019… https://t.co/G4FuspL3NK
h J R
Dr. Darrell White writes about the impact of age on efficacy and safety from the MAIA trial in transplant-ineligibl… https://t.co/00XDPvNCVo
h J R
Dr. Irwindeep Sandhu talks about the importance of studying real-world Canadian data in #multiplemyeloma #EHA2019… https://t.co/WHNsd75EPZ
h J R
Dr. Brian Leber discusses a re-analysis of the JAKARTA-2 study in patients with myeloproliferative neoplasm-associa… https://t.co/GyZFmwk7sq
h J R